Vanguard Global Advisers’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$57.9M Buy
156,210
+4,086
+3% +$1.44M 0.03% 382
2026
Q2
$54.6M Sell
152,124
-5,613
-4% -$1.72M 0.03% 393
2026
Q1
$39.5M Buy
+157,737
New +$39.2M 0.02% 457

Other funds holding WST

Vanguard Global Advisers's WST Position: Q3 2026 in Review

Vanguard Global Advisers increased its West Pharmaceutical (WST) stake by 2.7% in Q3 2026, buying an estimated $1.44M and bringing the position to 156,210 shares worth $57.9M. The position accounts for 0.03% of the portfolio, ranked #382.

Vanguard Global Advisers first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Vanguard Global Advisers held 156,210 shares of West Pharmaceutical worth $57.9M as of Q3 2026.
  • Vanguard Global Advisers bought 4,086 West Pharmaceutical shares in Q3 2026, an estimated $1.44M.
  • West Pharmaceutical made up 0.03% of Vanguard Global Advisers's portfolio in Q3 2026, its #382 holding.
  • Vanguard Global Advisers first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.